Form 8-K - Current report:
SEC Accession No. 0001641172-25-013803
Filing Date
2025-06-05
Accepted
2025-06-05 16:05:42
Documents
14
Period of Report
2025-06-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 44271
2 EX-99.1 ex99-1.htm EX-99.1 16438
3 EX-99.2 ex99-2.htm EX-99.2 15510
  Complete submission text file 0001641172-25-013803.txt   254903

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE maia-20250605.xsd EX-101.SCH 3023
5 XBRL LABEL FILE maia-20250605_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE maia-20250605_pre.xml EX-101.PRE 22364
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3784
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 251027103
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)